The central risk is value capture, not relevance. Arm is likely to matter more as AI spreads, but shareholders still need proof that higher-value
royalties, subsystems and silicon can scale faster than supply constraints, customer concentration,
export controls and partner pushback. With the stock already priced as strategic infrastructure, any wobble in royalty continuity,
AGI CPU conversion or ecosystem trust can compress returns even if the business keeps growing.